Benzinga | May 10, 2021 07:08AM EDT

Axsome Therapeutics Q1 EPS $(0.78) Beats $(0.87) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.87) by 10.34 percent. This is a 11.36 percent increase over losses of $(0.88) per share from the same period last year.